Influence of C4A deficiency on nonresponse to HBsAg vaccination: a new immune response gene.
作者信息
Milich David R
出版信息
J Hepatol. 2002 Sep;37(3):396-9. doi: 10.1016/s0168-8278(02)00237-4.
Abstract
摘要
相似文献
1
Influence of C4A deficiency on nonresponse to HBsAg vaccination: a new immune response gene.
J Hepatol. 2002 Sep;37(3):396-9. doi: 10.1016/s0168-8278(02)00237-4.
2
C4A deficiency and nonresponse to hepatitis B vaccination.
J Hepatol. 2002 Sep;37(3):387-92. doi: 10.1016/s0168-8278(02)00205-2.
3
Anti-HBV neonatal immunization with recombinant vaccine. Part II. Molecular basis of the impaired alloreactivity.
Vaccine. 1995 Apr;13(6):555-60. doi: 10.1016/0264-410x(94)00044-n.
4
[Hepatitis B vaccination in patients on chronic hemodialysis].
Lijec Vjesn. 2003 May-Jun;125(5-6):156-8.
5
Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination.
Vaccine. 2015 Feb 18;33(8):1084-91. doi: 10.1016/j.vaccine.2014.10.078. Epub 2014 Nov 7.
6
Prevention of hepatitis B infections: vaccination and its limitations.
Acta Clin Belg. 2001 Jul-Aug;56(4):209-19. doi: 10.1179/acb.2001.032.
7
Hepatitis B vaccination.
Nephrol Dial Transplant. 1997 Mar;12(3):623-4. doi: 10.1093/ndt/12.3.623.
8
Mathematical model of the antibody response to hepatitis B vaccines: implications for reduced schedules.
Vaccine. 2007 May 4;25(18):3705-12. doi: 10.1016/j.vaccine.2007.01.012. Epub 2007 Jan 23.
9
Clinical characteristics of hepatitis B virus infection in middle school students born after the universal infant vaccination program in Shanghai, China.
Arch Virol. 2012 May;157(5):901-5. doi: 10.1007/s00705-012-1251-9. Epub 2012 Feb 11.
10
[Active hepatitis B vaccination in ulcerative colitis treated with azathioprine].
Internist (Berl). 1999 Mar;40(3):327-8.
引用本文的文献
1
Complement C4 Gene Copy Number Variation Genotyping by High Resolution Melting PCR.
Int J Mol Sci. 2020 Aug 31;21(17):6309. doi: 10.3390/ijms21176309.
2
Hepatitis B surface antigen presentation and HLA-DRB1*- lessons from twins and peptide binding studies.
Clin Exp Immunol. 2005 May;140(2):325-32. doi: 10.1111/j.1365-2249.2005.02765.x.
3
Non-responsiveness to hepatitis B surface antigen vaccines is not caused by defective antigen presentation or a lack of B7 co-stimulation.
Clin Exp Immunol. 2005 Apr;140(1):126-37. doi: 10.1111/j.1365-2249.2004.02749.x.
Zotero 插件